1 to 3 of 3 literature results

• Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).

  BACKGROUND: Conventional treatment with epoetin to manage anaemia in chronic kidney disease needs frequent administrations, changes of dose, and close…

  Authors: Nathan W Levin, Steven Fishbane, Francisco Valdés Cañedo, Steven Zeig, George M Nassar, John E Moran, Giuseppe Villa, Ulrich Beyer, Delphine Oguey, MAXIMA study investigators

  Source: Lancet. 2007 Oct 20

  View Full Text

• Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study.

  BACKGROUND AND OBJECTIVES: Management of hyperphosphatemia, a predictor of mortality in chronic kidney disease, is challenging. Nonadherence to dietar…

  Authors: Rajnish Mehrotra, Kevin J Martin, Steven Fishbane, Stuart M Sprague, Steven Zeig, Michael Anger, Fosrenol Overview Research Evaluation Study for Early Experience Study Group

  Source: Clinical journal of the American Society of Nephrology : CJASN. 2008 Sep

  View Free Full Text

• Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.

  BACKGROUND: Adequate control of all four KDOQI biochemical targets for chronic kidney disease, bone and mineral disorder (CKD-MBD), which include para…

  Authors: Geoffrey A Block, Steven Zeig, Jared Sugihara, Glenn M Chertow, Eric M Chi, Stewart A Turner, David A Bushinsky, TARGET Investigators

  Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2008 Jul

  View Full Text